Innovators and Investors: The Journey from Entry to Exit
Tuesday, March 3, 2020

All sessions, presenters and times are subject to change without notice.
Breakfast & Lunch Buffet, and Free Parking, are included.
  • Full Agenda
  • 7:00 – 8:00 AM

    Registration, Breakfast and Networking


  • 8:15 – 8:30 AM

    Welcome from LSC’s Founder & Co-Chair, Steve Kantor (EVP KEH Insurance Agency)
    Opening Remarks
    from Paul Katz, MD, President of USciences


  • 8:30 – 9:00 AM

    Speaker #1: Chris Cashman
    Chairman, MBF Therapeutics


  • 9:05 – 10:00 AM

    Panel #1: Raising Capital – Real World Lessons
     
    Moderator: Dennis Steadman; President, Steadman Consulting, LLC and Steadman Capital LLC
    Speakers:
    Anthony P. Green, PhD; Vice President, Science and Technology, Ben Franklin Technology Partners of Southern Pennsylvania
    Daron Evans; Managing Director, PoC Capital
    Susan Dillon, PhD; Co-Founder, President and CEO, Aro Biotherapeutics Company
    Andrew Olsen; Principal, Boathouse Capital


  • Break
    10:00 – 10:25 AM

  • 10:30 – 11:25 AM

    Panel #2: Pricing
     
    Moderator: Amy Williams; President and Managing Partner, SageWorksRx LLC
    Speakers:
    Shekhar Yerramilli; Founder & CEO, The Guiding Start
    Joshua Parks; Founder, Chiral Logic
    Dr. Maria Lopes; Former Chief Medical Officer, MagellanRx
    Maximilian Vargas, PhD, MBA; Senior Director, US Access Strategy and Account Management, Certara


  •  
     
     
     
     
     
     
     
     
     

  • 11:30AM – 12:00 PM

    Speaker #2: Lou Kassa III MBA
    Executive VP & COO, Pennsylvania Biotechnology Center of Bucks Co, Baruch S. Blumberg Institute & Hepititis B Foundation


  •  

  • Lunch & Networking

    12:00 – 12:55 AM


  • 1:00 – 1:55 PM

    Panel #3: Great Expectations: The Real World of Licensing
     
    Moderator: Ihor Terleckyj; CEO, CuRAGE Therapeutics
    Speakers:
    Ahmet Hamdi Cavusoglu, Ph.D.; Director, Academnic Venture Exchange
    Michael Poisel; Executive Director, PCI Ventures
    Steve Nappi; Associate VP of Technology Commercialization & Business Development, Temple University
    Paul Jeffrey; Partner, BusStim, Virtual Biotech Accelerator


  •  
     
     
     
     
     
     
     
     
     
     
     
     
     

  • 2:00 – 2:55 PM

    Panel #4: Exits
     
    Moderator: Ryan Udell; Partner, White & Williams
    Speakers:
    Adele Oliva; Founding Partner, 1315 Capital
    John Gregg; CEO, BalinBac Therapeutics
    Matt Steere; Managing Director, Canaccord Financial
    Robert P. Ryan, PhD, D.A.B.T.; President & CEO, Innova Therapeutics, Inc


  •  
     
     
     
     
     
     
     
     
     
     
     
     
     

  • Break
    3:00 – 3:15 PM
  • 3:15 – 3:40 PM

    Speaker #3: Adam Lohr
    Partner & Senior Analyst, RSM US LLP


  •  
     
     

  • 3:45 – 4:05 PM

    Speaker #3: J. David Owens
    Biopharmaceutical Executive, Entrpreneur, Angel Investor, Board Member


  •  

  • Closing Remarks & Break for Networking

    4:05 PM